Seelos Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $376 | $579 | $653 | $406 |
Gross Profit | 361 | 564 | 638 | 392 |
EBITDA | -3,124 | -6,040 | -7,996 | -12,603 |
EBIT | -3,139 | -6,055 | -8,011 | -12,617 |
Net Income | 1,710 | -2,664 | -5,453 | 10,498 |
Net Change In Cash | 376 | 579 | 653 | 406 |
Free Cash Flow | -4,642 | -4,642 | -1,911 | -5,749 |
Cash | 294 | 524 | 2,996 | 2,584 |
Basic Shares | 2,515 | 13,007 | 9,794 | 4,937 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,203 | $808 | $0 | $375 |
Gross Profit | 2,146 | -53 | ||
EBITDA | -40,442 | -73,759 | -61,326 | -18,714 |
EBIT | -40,499 | -73,812 | -122,995 | -37,473 |
Net Income | -37,882 | -76,138 | -67,533 | -19,220 |
Net Change In Cash | 2,203 | 808 | 0 | 375 |
Cost of Revenue | -63,201 | 5,401 | ||
Free Cash Flow | -23,912 | -61,604 | -48,995 | -20,913 |
Cash | 2,996 | 15,533 | 78,734 | 15,662 |
Basic Shares | 4,900 | 3,544 | 3,029 | 1,492 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.12 |
2024-03-31 | -$1.63 |
2023-12-31 | -$0.79 |
2023-09-30 | -$0.12 |
